UK Markets closed

GlaxoSmithKline plc (GLAXF)


Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
21.490.00 (0.00%)
At close: 3:48PM EDT
People also watch
NVSEFRHHVFHBCYFBPAQFNSRGF
Full screen
Previous close21.49
Open0.00
Bid0.00 x
Ask0.00 x
Day's range0.00 - 0.00
52-week range
Volume43
Avg. volume1,711
Market cap104.64B
Beta1.17
PE ratio (TTM)48.40
EPS (TTM)N/A
Earnings dateN/A
Dividend & yield0.95 (5.02%)
Ex-dividend date2016-11-03
1y target estN/A
Trade prices are not sourced from all markets
  • Zacks10 hours ago

    Top Stock Reports for Alphabet, GlaxoSmithKline & T-Mobile

    Top Stock Reports for Alphabet, GlaxoSmithKline & T-Mobile

  • GlaxoSmithKline Plc breached its 50 day moving average in a Bearish Manner : GLAXF-US : July 21, 2017
    Capital Cube17 hours ago

    GlaxoSmithKline Plc breached its 50 day moving average in a Bearish Manner : GLAXF-US : July 21, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for GlaxoSmithKline Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Reuters18 hours ago

    GlaxoSmithKline's new CEO prepares to trim drug pipeline

    GlaxoSmithKline's new chief executive, who has already made her mark with plans to divest some nutritional products, will turn next week to the main business of focusing the company's pipeline of new drugs. Despite her non-pharmaceutical background in consumer brands, Emma Walmsley sees improving drug research productivity as her top priority, and she wants Britain's biggest drugmaker to have fewer but potentially more lucrative new medicine launches in future.